Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

TheraMAB

TheraMAB
2009 FOUNDED
OOB STATUS
1-10 EMPLOYEES
Out of Business LATEST DEAL TYPE
Description

Developer of an immunotherapeutic monoclonal drug designed to treat autoimmune diseases. The company's drug is used for the treatment of major diseases in the field of oncologyl, enabling physicians to begin treatment quickly and result in a higher likelihood of a successful treatment.

Website
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • Stolovy per. 6
  • Building 2
  • Moscow, 121069
  • Russia

+7 8 (000) 000-00-00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore TheraMAB’s full profile, request a free trial.

TheraMAB Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Sep-2018 000.00 Completed Out of Business
2. Early Stage VC 01-Mar-2012 000.00 000.00 Completed Clinical Trials - Phase 1
1. Grant 16-Feb-2012 $5M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

TheraMAB Executive Team (2)

Name Title Board
Seat
Contact
Info
Dmitry Tyrsin Ph.D Chief Executive Officer
Alexey Matskevich Ph.D Chief Researcher